ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.675,51
-0,27%
S&P 500
5.297,10
-0,21%
Dow Jones
39.869,38
0,00%
Euro vs US Dollar
1,0844
-0,22%
Bitcoin
66.212,44
1,50%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Enveric Biosciences Inc (ENVB)

  7. Enveric Biosciences Inc (ENVB) News

ENVB

Enveric Biosciences (ENVB)

Enveric Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ENVB
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202412h00Business WireEnveric Biosciences Reports First Quarter 2024 Financial and Corporate ResultsNASDAQ:ENVBEnveric Biosciences Inc
14/05/202414h00Business WireEnveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health DisordersNASDAQ:ENVBEnveric Biosciences Inc
08/05/202413h00Business WireEnveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using CannabinoidsNASDAQ:ENVBEnveric Biosciences Inc
26/03/202412h00Business WireEnveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023NASDAQ:ENVBEnveric Biosciences Inc
19/03/202412h00Business WireEnveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint DiseaseNASDAQ:ENVBEnveric Biosciences Inc
12/03/202412h00Business WireEnveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term SheetsNASDAQ:ENVBEnveric Biosciences Inc
11/03/202417h35Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ENVBEnveric Biosciences Inc
11/03/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
29/02/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
29/02/202413h00Business WireEnveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of CompoundsNASDAQ:ENVBEnveric Biosciences Inc
26/02/202422h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENVBEnveric Biosciences Inc
26/02/202422h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENVBEnveric Biosciences Inc
26/02/202422h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENVBEnveric Biosciences Inc
23/02/202414h00Business WireEnveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual PropertyNASDAQ:ENVBEnveric Biosciences Inc
21/02/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
21/02/202414h00Business WireEnveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health DisordersNASDAQ:ENVBEnveric Biosciences Inc
14/02/202421h36Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ENVBEnveric Biosciences Inc
09/02/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
06/02/202416h17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ENVBEnveric Biosciences Inc
05/02/202423h09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ENVBEnveric Biosciences Inc
24/01/202414h05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ENVBEnveric Biosciences Inc
23/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ENVBEnveric Biosciences Inc
11/01/202422h43Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ENVBEnveric Biosciences Inc
08/01/202422h42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
03/01/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
29/12/202322h43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
29/12/202314h52Business WireEnveric Biosciences Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.8 Million Gross Proceeds Priced At-the-MarketNASDAQ:ENVBEnveric Biosciences Inc
28/12/202314h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
28/12/202314h00Business WireEnveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 SeriesNASDAQ:ENVBEnveric Biosciences Inc
27/12/202314h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ENVB

Kürzlich von Ihnen besucht

BOV
CSNAF200
CSNAF200 Ex:19,28
BIT
UB4QDU
Unicredit Bank
BIT
UV4LJ9
UniCredit Bank
LSE
FC52
Bank Mont.24
BIT
SCOF7S
Societe Generale Effekten
COIN
SDLUSD
Saddle DAO
BIT
I07070
INTESA SANPAOLO
BIT
UV4LTC
UniCredit Bank
BIT
UC3QNK
Unicredit Bank
LSE
FD00
Cred Ag Co 29
BIBX
RLTUSDT
Relife Token
USOTC
ORMND
Orex Minerals (QB)
USOTC
PUODY
Promotora Y Operadora de... (PK)
USOTC
HWREF
Heiwa Real Estate REIT (PK)
OKEX
HSRBTC
LSE
SCA
Sports Cafe
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten